<VariationArchive VariationID="3241964" VariationName="NM_002801.4(PSMB10):c.40_42del (p.Phe14del)" VariationType="Deletion" Accession="VCV003241964" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-23" DateCreated="2024-06-17" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="3400941" VariationID="3241964">
      <GeneList>
        <Gene Symbol="PSMB10" FullName="proteasome 20S subunit beta 10" GeneID="5699" HGNC_ID="HGNC:9538" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>16q22.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="67934506" stop="67936850" display_start="67934506" display_stop="67936850" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="67968406" stop="67970779" display_start="67968406" display_stop="67970779" Strand="-" />
          </Location>
          <OMIM>176847</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_002801.4(PSMB10):c.40_42del (p.Phe14del)</Name>
      <CanonicalSPDI>NC_000016.10:67936707:GAAG:G</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>16q22.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="67936708" stop="67936710" display_start="67936708" display_stop="67936710" variantLength="3" positionVCF="67936707" referenceAlleleVCF="CGAA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="67970611" stop="67970613" display_start="67970611" display_stop="67970613" variantLength="3" positionVCF="67970610" referenceAlleleVCF="CGAA" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>F14del</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.67936709_67936711del" Assembly="GRCh38">
            <Expression>NC_000016.10:g.67936709_67936711del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.67970612_67970614del" Assembly="GRCh37">
            <Expression>NC_000016.9:g.67970612_67970614del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_051639.1" sequenceAccession="NG_051639" sequenceVersion="1" change="g.166_168del">
            <Expression>NG_051639.1:g.166_168del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_193674.1" sequenceAccession="NG_193674" sequenceVersion="1" change="g.30_32del">
            <Expression>NG_193674.1:g.30_32del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_002801.4" sequenceAccession="NM_002801" sequenceVersion="4" change="c.40_42del" MANESelect="true">
            <Expression>NM_002801.4:c.40_42del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_002792.1" sequenceAccession="NP_002792" sequenceVersion="1" change="p.Phe14del">
            <Expression>NP_002792.1:p.Phe14del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="176847.0002" DB="OMIM" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_002801.4(PSMB10):c.40_42del (p.Phe14del) AND Proteasome-associated autoinflammatory syndrome 5" Accession="RCV004577059" Version="1">
        <ClassifiedConditionList TraitSetID="65512">
          <ClassifiedCondition DB="MedGen" ID="C5543027">Proteasome-associated autoinflammatory syndrome 5</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2024-06-11" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-06-11" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-06-17" MostRecentSubmission="2024-06-17">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <CitationText>Hamosh, A. Personal Communication. 2024. Baltimore, Md.</CitationText>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">37600812</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="65512" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="55829" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Proteasome-associated autoinflammatory syndrome 5</ElementValue>
                <XRef ID="MONDO:0030924" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PRAAS5</ElementValue>
                <XRef Type="MIM" ID="619175" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18448" />
                <XRef ID="18448" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="C5543027" DB="MedGen" />
              <XRef ID="MONDO:0030924" DB="MONDO" />
              <XRef Type="MIM" ID="619175" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="9830115" SubmissionDate="2024-06-11" DateLastUpdated="2024-06-17" DateCreated="2024-06-17">
        <ClinVarSubmissionID localKey="176847.0002_PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 5" title="PSMB10, 3-BP DEL, NT40_PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 5" />
        <ClinVarAccession Accession="SCV005060849" DateUpdated="2024-06-17" DateCreated="2024-06-17" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-06-11">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 3 unrelated Brazilian boys (P2, P3, and P4) with proteasome-associated autoinflammatory syndrome-5 (PRAAS5; 619175), Papendorf et al. (2023) identified compound heterozygous mutations in the PSMB10 gene. All 3 patients carried a heterozygous 3-bp in-frame deletion (c.40_42del, NM_002801.4), resulting in the deletion of conserved residue Phe14 (Phe14del) in the propeptide, on 1 allele. On their respective other alleles, P2 carried a heterozygous c.500G-A transition, resulting in a gly167-to-asp (G167D; 176847.0003) substitution; P3 carried a heterozygous 1-bp insertion (c.247_248insT; 176847.0004) predicted to result in a frameshift and premature termination (Cys83LeufsTer123); and P4 carried a heterozygous c.710+1G-C transversion in intron 7 (176847.0005), resulting in a splicing defect and the skipping of exon 7. The mutations, which were found by exome sequencing and confirmed by Sanger sequencing, segregated with the disorder in all families. The authors stated that the Phe14del and splice site mutations were not present in the gnomAD database, whereas G167D was found once in the heterozygous state (frequency of 3.9 x 10(-6)), and c.247insT was found 28 times in the heterozygous state (frequency of 0.0001, mostly in individuals of African ancestry). Patient cells were not available for study, but transfection of 2 the mutations into HeLa cells showed that the Phe14del and G167D variants were expressed, but not incorporated into mature proteasomes. In addition, the G167D mutation resulted in reduced protein levels compared to controls. The frameshift mutation was predicted to undergo nonsense-mediated mRNA decay with no protein produced, consistent with a loss of function. Structural modeling suggested that the splice site mutation would affect the formation of precursor complexes that precede incorporation of the PSMB10 subunit into the mature proteosome.</Attribute>
              <Citation>
                <ID Source="PubMed">37600812</ID>
              </Citation>
              <XRef DB="OMIM" ID="619175" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Hamosh (2024) noted that the c.247insT mutation was present in 74 of 1,609,244 alleles, in heterozygosity only, in the gnomAD database (v4.1), for an allele frequency of 4.60 x 10(-5). The G167D mutation was not present in gnomAD (v4.1).</Attribute>
              <Citation>
                <CitationText>Hamosh, A. Personal Communication. 2024. Baltimore, Md.</CitationText>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PSMB10" />
          </GeneList>
          <Name>PSMB10, 3-BP DEL, NT40</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">3-BP DEL, NT40</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="176847.0002" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 5</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="9830115" TraitType="Disease" MappingType="Name" MappingValue="PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 5" MappingRef="Preferred">
        <MedGen CUI="C5543027" Name="Proteasome-associated autoinflammatory syndrome 5" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

